2015

1. Is intermediate radiation dose escalation with concurrent chemotherapy for stage III non-small-cell lung cancer beneficial? A multi-institutional propensity score matched analysis

   International Journal of Radiation Oncology Biology Physics, Vol. 91, Núm. 1, pp. 133-139